GWASs and the age of human as the model organism for autoimmune genetic research.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Aberrant Expression ofCancers · 2025
   Article
2. Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway.PLoS genetics · 2013
   Article
3. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.Immunity · 2012
   Review
4. Balancing selection is common in the extended MHC region but most alleles with opposite risk profile for autoimmune diseases are neutrally evolving.BMC evolutionary biology · 2011
   Article
5. A decade and genome of change.Genome biology · 2010
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as